REPL Earnings

REPL reported its FY2026Q1 earnings on 2025-08-07, showcasing a revenue of 0.00 against an estimate of 1.00K, resulting in a -100% surprise. The EPS was -0.95, surpassing the expected -0.83 by -14.46% . The stock experienced a -0.36% price change on the earnings day and a -4.55% change over the next five days, reflecting market reactions to the results.

Following REPL's FY2026Q1 earnings announcement on 2025-08-07, the stock price moved by -0.36% on the day of the release. Over the subsequent five days, it saw a -4.55% change. Historically, REPL's stock price tends to shift by an average of +0.78% in the 10 days leading up to earnings and -0.06% in the 10 days following, providing insight into potential market.

For , analysts estimate REPL’s annual revenue to reach undefined, while the EPS is projected at -1.00. These estimates reflect recent revisions, with revenue estimates revised Revenue No Change by 0% and EPS estimates No Change by 0% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between REPL's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2026 were No Change by 0%, while EPS estimates moved No Change by 0% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, REPL's stock price typically moves by +0.78% in the 10 days before its earnings and -0.06% in the 10 days after. For the upcoming earnings, analysts expect an EPS of -1.00 and revenue of undefined.

The earnings call reveals significant financial strain with increasing net losses and operational costs, despite a rise in cash reserves. The absence of a share repurchase program and unclear management responses during the Q&A further contribute to uncertainty. While there is optimism around the RP1 launch and regulatory progress, the lack of specific revenue guidance and potential commercial launch risks weigh negatively. Overall, the financial performance and operational challenges suggest a negative sentiment, likely leading to a stock price decline between -2% to -8%.